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Abstract: The typical morphology of common
bile duct strictures in chronic pancreatitis
suggests a pathogenesis not of encasement,
but of mural changes in the common bile duct.
Cerulein, 20 µg/kg was administered to male
Wistar rats in four subcutaneous doses,
hourly for 3 h, and was recorded as one
application. Group A served as controls and
received subcutaneous saline. Group B1
received one application of Cerulein and was
sacrificed after 24 h. Group B2 was similar to
B1, but was sacrificed two weeks later. Group
B3 was given two applications of Cerulein
with an interval of two weeks and was
sacrificed two weeks after the second
application. Group B4 received one application
of Cerulein every week for four weeks and
was sacrificed two weeks after the last
application.

1

4

Departments of Surgery, Pathology, Faculty
3
of Medicine, Ege University, Pathology
Laboratory, SSK Yeniflehir Hospital, ‹zmir;
2
Department of Surgery, Faculty of Medicine
Celal Bayar University, Manisa - Turkey

Introduction
Extrahepatic cholestasis is a well known complication
of chronic pancreatitis (1-3). Although only 3 to 8% of
patients experience persistent jaundice, cholestasis in the
course of the disease may be seen in 27 to 45% of the
patients in various series (4-6). The cholestasis of chronic
pancreatitis may be partly induced by the edema and
inflammation accompanying the disease, as the distal
common bile duct is enveloped in the pancreatic head in
75% of the human population (7). However, in most
patients presenting with persistent jaundice due to
extrahepatic biliary obstruction, the fundamental disorder
is attributed to the compression and/or infiltration of the
biliary passage by fibrosis associated with chronic
pancreatitis. This acceptance has led to surgical
procedures that relieve jaundice with local resections or
resections that preserve the duodenum and even the
integrity of the common bile duct (8). Hence, there is
reasonable evidence that extrahepatic jaundice in chronic
pancreatitis is due to encasement of the common bile duct
by the surrounding pancreas. However, there is no
evidence that excludes the possibility of intramural

Serum amylase levels, pancreatic edema and
peripancreatic inflammatory infiltration scores
increased with the severity and persistance of
the insult. Bilirubin and alkaline phosphatase
levels suggested cholestatic response in the
groups that received repeated insults with
Cerulein (Groups B3 and B4; p < 0.01).
Moderate to strong immuno-histochemical
positivity for type IV collagen at the wall of
the common bile duct in animals with a
persisting insult is suggestive of circumstantial
evidence for mural changes as a causative
factor of stricture formation in similar
settings such as chronic pancreatitis with
persistent inflammatory attacks.
Key Words: Pancreatitis, chemically induced;
Pancreatitis, complications; Bile duct
strictures; Rat pancreatitis.

fibrosis in the common bile duct, resulting from repeated
inflammatory attacks during the course of this chronic
process. In this study, we examined the effects of
repeated inflammatory attacks of the pancreas on the
structural changes of the common bile duct in a rat
model.
Materials and Methods
Cerulein, at a dose of 20 µg/kg, was administered to
male Wistar albino rats, six weeks of age, weighing 120
to 180 g. The total dose of Cerulein was delivered in four
hourly subcutaneous injections, recorded as one
application. The rats were divided into five groups. Group
A (n = 3) served as controls and received one application
of isotonic saline subcutaneously. Group B1 (n = 5) rats
received one application of Cerulein and were sacrificed
24 h after the last injection. Group B2 rats (n = 7)
received one application of Cerulein, and were sacrificed
two weeks later. Group B3 rats (n = 7) were given two
applications of Cerulein at an interval of two weeks and
were sacrificed two weeks after the last application of the
drug. Group B4 rats (n = 7) received one application of
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Cerulein every week for four weeks and were sacrificed
two weeks after the last application.
The animals were fed commercially available standard
chew and had free access to water throughout the
protocol. The rats were sacrificed by guillotine
decapitation under ether anesthesia. Blood samples were
analyzed for ALT, AST, amylase, alkaline phosphatase,
and total and direct bilirubin using an Express 550 CibaCorning Autoanalyzer. The abdomen was swiftly opened
and the liver, bile ducts and pancreas were removed enbloc for histopathological examination.
A light microscopic examination was performed after
the tissue samples were dyed with hematoxylin and eosin.
Gomori's methenamine silver dye method and Masson's
trichrome method were used to assess the connective
tissue response. All tissue samples were examined
immediately after the respective group of rats were
sacrificed; the pathologist was blind to the groups. A
scoring system was created to enable comparison
between the groups. Pancreatic, peripancreatic and
choledochal cellular inflammatory changes were graded
as shown in Table 1.
Mural fibrinogen, laminin and type IV collagen were
examined immunohistochemically as predictors of fibrosis
of the common bile duct. Their presence was evaluated by
using Dako Laboratories (Carpinteria, CA, USA)
monoclonal Mouse Anti-Human Collagen IV, Rabbit AntiHuman Fibrogen, and Monoclonal Mouse Anti-Human
Laminin primary antibodies; with Universal LSAB Kit, AEC
Substrate-Cromogen and water soluble Harris
Hematoxylin for counterstaining. A separate scoring
system (Table 2) was used to evaluate the
immunohistochemical results.
The results of biochemical studies were analyzed by
Student's t-test. The Kruskal-Wallis test was employed to
detect
differences
in
histopathological
and
immunohistochemical results between the groups.
Whenever a difference was detected by the Kruskal-Wallis
test, the Mann-Whitney Rank Sum test was used to
explore significance between the groups. At least p =
0.05 was regarded as statistically significant.
Results
The biochemical results for all groups are shown as
mean (± SEM) values in Table 3. The serum amylase was
680 (92.7) U/L for Group A controls, 1350 (24.7) U/L
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Table 1.

Scoring for Histopathological Evaluation.

Pancreatic:
Edema:
0
1
2
3

Absent
Mild
Moderate
Significant

Inflammatory Cellular Infiltration
(Polymorphonuclear and mononuclear):
0
No cellular infiltration
1
Homogeneous cellular infiltration
2
Cluster-like cellular infiltration
Peripancreatic Inflammatory Cellular Infiltration:
0
Groups of mononuclear cells within fat tissue,
with normal pancreatic architecture
1
Two-fold increase in mononuclear cells in
peripancreatic fat
2
Inflammatory infiltration including
polymorphonuclear leucocyte
within peripancreatic fatty tissue
Choledochal:
Edema:
0
1
2

Absent
Mild
Significant

Cellular Infiltration:
0
No polymorphonuclear cellular infiltration at the
wall of the CBD
1
Mild polymorphonuclear cell infiltrates at the
wall of the CBD
2
Significant polymorphonuclear cellular infiltration
Mural Connective Tissue:
0
No increase in the amount of connective tissue
or reticulum fibers
1
Increase in the amount of connective tissue and
reticulum fibers.
Table 2.

Scoring for Immunohistochemical Evaluation.

Common Bile Duct Wall Fibrinogen:
0
Negative
1
Mild positive
2
Moderate positive
Common Bile Duct Wall Laminin Content:
0
Negative
1
Mild positive
2
Moderate positive
Common Bile Duct Wall Type IV Collagen Content:
0
Negative
1
Mild positive
2
Moderate positive
3
Strong positive
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Table 3.

Biochemical results for all groups. The figures are means (±SEM). All results are in U/L, except bilirubin (mg/dL).

Amylase
Alkaline Phosph.

Group A

Group B1

680 (±92.7)

13501 (±24.7)

86 (±13.9)

67.6 (±10.0)

ALT

94.3 (±6.2)

97.6 (±9.6)

AST

63.3 (±7.5)

67.2 (±5.6)

Bilirubin

0.8 (±0.2)

1.3 (±0.2)

Group B2

Group B3

Group B4

712 (±57.6)

24641 (±110)

25371 (±52.2)

93.9 (±8.8)

316.72 (±21.8)

424.32 (±20.2)

102.14 (±5. 2)
72.8 (±3.6)
1.5 (±0.2)

3

206.0 (±15.2)
86.45 (±4.4)
6

3.1 (±0.4)

197.03,4 (±14.6)
93.15 (±1.2)
4.06,7 (±0.1)

1

Statistically significant compared to Group A (B1, p < 0.05; B3, p < 0.01; B4, p < 0.01). 2 Significant compared to Group A (B3, p < 0.01; B4,
p < 0.01), to Group B1 (B3, p < 0.05; B4, p < 0.005) and to Group B2 (B3, p < 0.001; B4, p < 0.001). 3 Significant, compared to Group A (B3,
p < 0.01; B4, p < 0.01) and to Group B1 (B3, p < 0.005; B4, p < 0.005). 4 Significant, compared to Group B2 (p < 0.001). 5 Significant,
compared to Group A (B3, p < 0.05; B4, p < 0.01), to Group B1 (B3, p < 0.05; B4, p < 0.05), and to Group B2 (B3, p < 0.05; B4, p < 0.01).
6
Significant compared to Group A (B3, p < 0.01; B4, p < 0.01), to Group B1 (B3, p < 0.005; B4, p < 0.005) and to Group B2 (B3, p < 0.001;
B4, p < 0.001). 7 Significant compared to Group B3 (p < 0.05).

for Group B1, 712 (57.6) U/L for Group B2, 2464 (110)
U/L for Group B3 and 2537 (52.2) U/L for Group B4.
Compared to the controls, the serum amylase increased
significantly in B1 (p < 0.05), B3 (p < 0.01) and B4 (p <
0.01). There were also significant differences between
Groups B1 and B2 (p < 0.005), B2 and B3 (p < 0.001)
and B2 and B4 (p < 0.001), indicating that the increase
in the cerulein insult produced more marked
hyperamylasemia.
Similarly, both alkaline phosphatase and serum
bilirubin exhibited steady increases parallel to the increase
in the persistence of the Cerulein insult. Alkaline
phosphatase was 86 (13.9) U/L in the controls; however,
this rose to 316.7 (21.7) U/L in B3 (p < 0.01) and 424.3
(20.1) U/L in B4 (p < 0.01). There were also statistically
significant differences between B1 versus B3 (p < 0.05)
and B4 (p < 0.005), B2 versus B3 (p < 0.001) and B4 (p
< 0.001), and between B3 and B4 (p < 0.01). The
bilirubin values were 0.83 (0.24) mg/dL for Group A,
1.28 (0.18) mg/dL for B1, 1.48 (0.16) md/dL for B2,
3.14 (0.35) mg/dL for B3 and 4.0 (0.15) mg/dL for B4.
The increase was significant between Groups A and B3 (p
< 0.01), A and B4 (p < 0.01), B1 and B3 (p < 0.005),
B1 and B4 (p < 0.005), B2 and B3 (p < 0.001), and B2
and B4 (p < 0.001). There was also a significant increase
between Groups B3 and B4 (p < 0.05). These results
suggest that the bile flow is disturbed as the pancreatic
inflammatory insult is increased.
Serum ALT and AST values were also in accord with
the general biochemical response to the model employed.

They both revealed statistically significant increases in
Groups A to B4 (Table 3).
Light microscopic and immunohistochemical results
are shown in Tables 4 and 5, respectively. The results are
expressed as the percentage of the animals in the group
that exhibited the parameter. Statistical evaluation
revealed significance only for light microscopic data for
pancreatic edema and peripancreatic inflammatory
infiltration. Pancreatic edema was significant between
Groups A and B1 (p = 0.037), A and B4 (p = 0.05), B1
and B3 (p = 0.018), and B1 and B4 (p = 0.008).
Peripancreatic inflammatory cellular infiltration was
significantly different between Groups B1 and B3 (p =
0.05), B2 and B4 (p = 0.02), and B3 and B4 (p = 0.005).
All other differences between the groups were
insignificant.

Discussion
Choledochal strictures in chronic pancreatitis are
generally attributed to periductal fibrosis from long
standing disease (9). It is believed that when periductal
inflammation progresses to fibrosis a fixed stricture
results (10) . This belief is a direct extention of the
assumption that the pathologic characteristic is
encasement of the common bile duct within the pancreas
or in its immediate vicinity (11). However, the typical
choledochal stricture of chronic pancreatitis is
characteristically a long, smooth, gradual tapering of the
distal common bile duct (3,10,11). This stricture

459

Bile Duct Response to Repeated Cerulein Induced Pancreatitis in the Rat

Table 4.

The results of histopathological evaluation.

Groups

A

B1

B2

B3

B4

Inflammatory Cellular Infiltration
Homogeneous cellular infiltration
Cluster-like cellular infiltration

66.7%
-

60.0%
-

42.9%
14.3%

57.2%
42.9%

5.7%
14.3%

Pancreatic Edema
Mild
Moderate
Significant

33.0%
-

100%
-

42.9%
14.3%
-

85.7%
14.7%

28.6%
71.4%

Peripancreatic Inflam. Infiltration
Groups of mononuclears in fatty tissue
Two-fold increase in mononuclears
Polymorphonuclears in inflam. infiltrate

66.7%
33.3%
-

100%
-

57.1%
42.0%
-

85.7%
14.7%
-

14.3%
28.6%
57.1%

Common Bile Duct (CBD) Edema
Mild
Significant

-

100%
-

57.1%
-

42.9%
14.3%

42.9%
57.1%

CBD Cellular Infiltration
Mild polymorphonuclear infiltration
Significant polymorphonucl. infiltration

-

80.0%
-

71.4%
-

71.4%
14.3%

71.4%
28.6%

CBD Connective Tissue and Reticulum Fiber
No increase
Increased

100%
-

100%
-

100%
-

100%
-

100%
-

Table 5.

The results of immunohistochemical parameters at the common bile duct wall.

Groups

A

B1

B2

B3

B4

Fibrinogen
Negative
Mild positive
Moderate positive

100%
-

100%
-

100%
-

100%
-

100%
-

Laminin
Negative
Mild positive
Moderate positive

1/3*
1/3
1/3

20.0%
40.0%
40.0%

85.7%
14.3%

14.3%
71.4%
14.3%

57.1%
42.9%

Type IV Collagen
Negative
Mild positive
Moderate positive
Strong positive

66.7%
33.3%
-

80.0%
20.0%
-

71.4%
28.6%
-

42.9%
14.3%
42.9%
-

57.1%
28.6%
14. 3%

* Group A (normal controls) consisted of three rats.
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morphology casts doubt on the encasement theory,
especially when patients affected by this complication are
those with pancreatic calcification, steatorrhea or
endocrine insufficiency (9) due to long standing
pancreatic disease. In such an instance, it would be logical
to expect a deformed bile duct due to penetration by
different degrees of fibrosis at different sites within the
encasing pancreas, as seen in the pancreatic duct. Indeed,
a minority of the common bile duct strictures in chronic
pancreatitis suggest such a pathologic evolvement with
their hourglass appearance (9,12). However, smooth,
gradual tapering of the distal common bile duct suggests
some degree of mural response instead. Both clinical and
experimental evidence is present to support such a
hypothesis. The encasement theory does not explain
restenoses of biliary anastomoses outside the pancreas
(13), nor is it consistent with the inflammatory findings
in the bile duct and gallbladder of affected patients (14).
It is well known that patients with chronic pancreatitis
experience acute inflammatory exacerbations during the
course of their disease. Induced edematous pancreatitis
with a supramaximal dose of Cerulein is a well known
model in the rat (15). Pancreatitis of this extent causes
reversible homogeneous ultrastructural changes in the rat
pancreas (16-18), is a controlled model, can be repeated
and is rarely fatal (19). The rat bile duct serves to collect
both the bile secretion of the liver, and the pancreatic
juice secreted by the pancreas lobules surrounding the
duct on its course to the duodenum (20). The experiment
protocol allowed sufficient time for the pancreas to
recover from the acute insult produced by Cerulein and
counteract biochemical disturbances attributable to
external compression by the swollen pancreas lobules.
Although there is evidence that acute hemorrhagic
pancreatitis may evolve into chronic pancreatitis with duct
obstructing strictures after intraductal administration of
bile salts (21), in this study we did not aim to produce
chronic pancreatitis, but to construct a model to follow
common bile duct response to a standard inflammatory
insult of increasing persistance. A similar model was
employed by Vaquero et al. (22), who gave Cyclosporin
to some groups in addition to Cerulein to cause a
response simulating chronic pancreatitis. The model we
constructed has enabled the desired insult, as evidenced
by the degree of pancreatic edema shifting from mild to
significant and by the degree of the biochemical response

as the intensity of Cerulein administration increased. Rats
that received repeated Cerulein insults had higher
pancreatic injury responses and bile flow disturbances
than both control and single application groups, as
reflected in Tables 3 and 4.
There was no significant difference in the parameters
between control animals and B2 animals, or between
Groups B1 and B2, indicating that the usual pancreatic
response to a single application of Cerulein recovers
within a week. However, response to the insult was
sustained as the Cerulein applications were repeated. This
is similar to a previous experience that reports delayed
regeneration after repeated Cerulein administrations
(23). The alkaline phosphatase and bilirubin levels
showed parallel increases that suggested a cholestatic
state, again as the insult was repeated. There was no
difference between the choledochal cellular infiltration
between the groups, although polymorphonuclear
infiltration was more prominent (n.s.) in B3 and B4 rats
with sustained Cerulein insult. Significant edema in the
common bile duct wall was present also, in 57% of the
animals in group B4. However, there was no increase in
the connective tissue and reticulum fiber content of the
common bile duct, and fibrinogen was negative
immunohistochemically in all groups.
Elsasser et al. (24) showed that hydroxyproline
content, acinar cell destruction, cellular infiltration and
collagen deposition persisted during the first week of
repeated Cerulein insults, but repetitive induction of
pancreatitis did not result in pancreatic fibrosis. A similar
conclusion can be made for the bile duct response to
repeated Cerulein insults as well. Although it has been
shown that bile duct epithelial cells are destroyed after
acute interstitial pancreatitis with intraperitoneal or
intravenous dibutyltin dichloride (25), the present study
failed to detect the results of such destruction in a
Cerulein model. Nevertheless, the tendency of the
microscopic findings and the presence of moderate to
strong immunohistochemical positivity for type IV
collagen at the wall of the common bile duct in animals
with a persisting insult, albeit statistically non-significant,
may suggest circumstantial evidence for doubt that
encasement by a fibrotic pancreas is not the only
explanation for common bile duct strictures in chronic
pancreatitis.
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